Cargando…
DAB2IP decreases cell growth and migration and increases sensitivity to chemotherapeutic drugs in colorectal cancer
BACKGROUND: Colorectal cancer (CRC) is one of the most common cancers worldwide with high rates of invasiveness and mortality. DAB2IP (DOC2/DAB2 interactive protein) is a member of the RAS-GTPase-activating protein (RAS-GAP) family that shows a suppressive effect on cancer progression, is downregula...
Autores principales: | Wu, Guanting, Xu, Xin, Wan, Daiwei, Zhou, Diyuan, Feng, Yuan, Chen, Junjie, Peng, Zhijian, Fang, Dong, Shi, Xinyu, Yao, Huihui, Chen, Guoliang, Sun, Liang, Yao, Yizhou, Zhou, Guoqiang, Yang, Yili, He, Songbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422087/ https://www.ncbi.nlm.nih.gov/pubmed/34532454 http://dx.doi.org/10.21037/atm-21-3474 |
Ejemplares similares
-
STING promotes proliferation and induces drug resistance in colorectal cancer by regulating the AMPK-mTOR pathway
por: Yao, Huihui, et al.
Publicado: (2022) -
TBK1 Facilitates GLUT1-Dependent Glucose Consumption by suppressing mTORC1 Signaling in Colorectal Cancer Progression
por: Zhou, Diyuan, et al.
Publicado: (2022) -
DAB2IP Downregulation Enhances the Proliferation and Metastasis of Human Gastric Cancer Cells by Derepressing the ERK1/2 Pathway
por: Sun, Liang, et al.
Publicado: (2018) -
Erratum to “DAB2IP Downregulation Enhances the Proliferation and Metastasis of Human Gastric Cancer Cells by Derepressing the ERK1/2 Pathway”
por: Sun, Liang, et al.
Publicado: (2020) -
Pretreatment blood biomarkers combined with magnetic resonance imaging predict responses to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Shi, Xinyu, et al.
Publicado: (2022)